What Happened
- The US Supreme Court, in a 6-3 ruling on February 20, 2026 (Learning Resources, Inc. v. Trump), struck down President Trump's broad tariffs imposed via the International Emergency Economic Powers Act (IEEPA), holding the statute does not authorise tariff-setting powers.
- The ruling potentially opens the door to over $100 billion in tariff refunds for importers who paid IEEPA-based reciprocal tariffs since their imposition.
- Approximately 60% of Indian exports to the US were subject to the IEEPA-based reciprocal tariffs — their removal is a significant relief for Indian exporters in textiles, gems, pharmaceuticals, and engineering goods.
- Following the ruling, Trump issued a new 10% global tariff executive order (later raised to 15%) using an alternative legal basis — analysts note this lower rate significantly reduces the tariff burden compared to the original 25% on India.
- However, sectoral tariffs (Section 232 on steel/aluminium at 50%, plus the suspension of de minimis exemptions) remain in force and continue to affect Indian exporters.
Static Topic Bridges
IEEPA and Presidential Tariff Authority — The Constitutional Separation of Powers Question
The IEEPA ruling engages a fundamental question in US constitutional law: the non-delegation doctrine and the extent of congressional authority delegation to the executive branch. Article I, Section 8 of the US Constitution gives Congress the exclusive power to "lay and collect taxes, duties, imposts and excises." Congress can delegate regulatory authority to the executive, but the Supreme Court has increasingly scrutinised whether such delegations are within constitutional bounds. In Learning Resources v. Trump, the majority held that IEEPA's text — which allows the President to "regulate" transactions — does not extend to imposing tariffs, an extraordinary power Congress would have expressly stated.
- US Constitution Article I, Section 8: Congress has exclusive power to levy tariffs and duties
- IEEPA (1977): allows President to "block," "prohibit," and "regulate" international economic transactions — does not mention tariffs
- Non-delegation doctrine: Congress cannot grant unlimited legislative power to the executive without an "intelligible principle" to guide its use; reinvigorated by recent SCOTUS decisions
- Major Questions Doctrine: established in West Virginia v. EPA (2022) — agencies cannot claim authority over issues of major economic and political significance without clear congressional authorization; applied in the IEEPA context
- Three other statutory bases for US tariffs remain valid (not struck down): Section 232 (Trade Expansion Act 1962, national security), Section 301 (Trade Act 1974, unfair foreign trade practices), Section 201 (Trade Act 1974, safeguard tariffs)
- India's equivalent: India's tariff-setting authority rests with Parliament through Finance Bills; delegated to the government via the Customs Tariff Act 1975 and Customs Act 1962
Connection to this news: The SCOTUS ruling limits presidential tariff unilateralism — reaffirming that comprehensive tariff regimes require explicit congressional authorisation rather than emergency powers, with significant implications for global trade policy certainty.
WTO Dispute Settlement and India's Trade Interests
The World Trade Organization (WTO) provides the multilateral framework for trade dispute resolution. India has been an active participant in WTO disputes. The IEEPA tariff issue, while resolved through domestic US judicial action, intersects with WTO obligations: WTO members cannot impose tariffs above their bound rates without a valid exception (national security — GATT Article XXI, or General Exceptions — Article XX). India has previously challenged US Section 232 steel tariffs at the WTO, filing a complaint in 2018.
- WTO Dispute Settlement: Panel → Appellate Body (currently non-functional due to US blocking new appointments since 2017) → Multi-Party Interim Appeal Arbitration Arrangement (MPIA) used as alternative
- GATT Article XXI (Security Exception): allows members to take trade-restricting measures they consider necessary for national security — a self-judging standard, but Russia v. Ukraine WTO panel (2019) and US Steel/Aluminium panels have found it is not entirely beyond WTO review
- India's WTO challenge to US Section 232: filed 2018; panel established, but proceedings complex
- India's bound tariff rates (WTO commitments): India's bound rates are significantly higher than applied rates, giving India more flexibility to raise tariffs than many developed countries
- India is the world's 9th largest merchandise exporter and 8th largest importer (WTO 2024 estimates)
Connection to this news: The SCOTUS ruling provides domestic US relief to affected importers, but the WTO-level complaints about US tariff practices remain — the ruling may reduce some WTO litigation urgency but does not resolve the broader question of US compliance with MFN obligations.
India-US Trade Architecture — Export Exposure and Sectoral Impact
India's export basket to the US is heavily concentrated in sectors that were targeted by the IEEPA reciprocal tariffs: pharmaceuticals, textiles, gems and jewellery, engineering goods, and chemicals. The 60% exposure figure refers to the proportion of Indian merchandise exports to the US that were subject to the 25% IEEPA reciprocal tariff. With this tariff now struck down (and replaced with a lower 10-15% executive order tariff), Indian exporters in these sectors gain significant competitiveness.
- Total India-US goods exports (2024-25): $86.5 billion
- ~60% of Indian exports subject to the IEEPA reciprocal tariff: ~$52 billion worth
- Key export sectors affected: Pharmaceuticals ($8B — critical since 40% of US generic drugs come from India), Gems and jewellery ($9B), Textiles and apparel ($8.5B), Engineering goods, Chemicals
- India's pharmaceutical exports to US: India supplies ~40% of US generic pharmaceutical demand; ~30% of US OTC drug demand — making this a strategically sensitive sector for both countries
- $100B+ in potential US import tariff refunds: applies to all importers from all countries who paid IEEPA-based tariffs; not India-specific
- India's exports likely to benefit most from SCOTUS ruling: labour-intensive sectors (textiles, apparel, footwear) that compete on price and were hardest hit by the 25% tariff
Connection to this news: The data charts in the original analysis quantify a significant asymmetric impact — India's export sectors with the highest US exposure were precisely those hit hardest by the IEEPA tariffs, meaning the SCOTUS ruling disproportionately benefits India compared to other trading partners less exposed to the US.
Key Facts & Data
- SCOTUS ruling: Learning Resources, Inc. v. Trump, February 20, 2026; 6-3 majority
- IEEPA-based tariff on India: 25% reciprocal tariff (now struck down)
- Post-ruling US global tariff (executive order): 10-15% (non-IEEPA basis)
- % of Indian exports subject to IEEPA tariffs: ~60%
- Potential US tariff refund pool: $100 billion+ (all countries combined)
- India-US goods exports (2024-25): $86.5 billion
- India's share of US generic pharmaceutical market: ~40%
- Section 232 tariffs (still in effect): 50% on steel and aluminium
- De minimis exemption: suspended August 2025; remains suspended post-ruling
- India-US interim BTA: expected formal signing April 2026
- WTO Appellate Body: non-functional since 2017 (US blocking appointments)